Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 1528

BillFederalSenateIn Committee
Genetically Engineered Salmon Labeling Act
About This Bill
Committee
Latest Action · July 11, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
115th (2017–2019)
Introduced
July 11, 2017
Cosponsors (3)
2D 1R
View PDF ↗

Summary

Highlight any text to annotate
Genetically Engineered Salmon Labeling Act This bill requires the market name of genetically engineered (commonly called "genetically modified" or "GMO") salmon to include "Genetically Engineered" or "GE" in front of the existing market name. The Department of Health and Human Services must ensure that an independent scientific and technical advisory organization reports on: (1) the Food and Drug Administration (FDA) environmental assessment of AquAdvantage Salmon, and (2) each FDA environmental assessment in support of approval of a new animal drug application for a genetically engineered finfish intended for human consumption. Upon receipt of a report from the independent organization, the FDA must conduct a second environmental assessment of the fish, taking into account the report's findings. The approval of a new animal drug application for a genetically engineered fish does not take effect until the second environmental assessment of the fish is completed.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.